Literature DB >> 29659326

Author reply to VA-MENGOC-BC cross-protection (2018HV0022).

Helen Petousis-Harris1.   

Abstract

Mesh：

Year:  2018        PMID： 29659326      PMCID： PMC5989880          DOI： 10.1080/21645515.2018.1448335

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  3 in total

Review 1.  Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review.

Authors:  Thomas Harder; Judith Koch; Ole Wichmann; Wiebke Hellenbrand
Journal:  J Infect       Date:  2017-05-06       Impact factor: 6.072

Review 2.  Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.

Authors:  Johan Holst; Philipp Oster; Richard Arnold; Michael V Tatley; Lisbeth M Næss; Ingeborg S Aaberge; Yvonne Galloway; Anne McNicholas; Jane O'Hallahan; Einar Rosenqvist; Steven Black
Journal:  Hum Vaccin Immunother       Date:  2013-03-07       Impact factor: 3.452

3.  Cross-protection induced by VA-MENGOC-BC® vaccine.

Authors:  Rolando Felipe Ochoa-Azze
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.